North American cranberry (Vaccinium macrocarpon) stimulates apoptotic pathways in DU145 human prostate cancer cells in vitro

Nutrition and Cancer

Volumn 63, Issue 1, 2011, Pages 109-120

  MacLean, Malcolm A ^a   Scott, Bradley E ^a   Deziel, Bob A ^a   Nunnelley, Melissa C ^b   Liberty, Anne M ^b   Gottschall Pass, Katherine T ^a   Neto, Catherine C ^b   Hurta, Robert A R ^a  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^b UNIVERSITY OF MASSACHUSETTS DARTMOUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHOCYANIN; CASPASE 8; CASPASE 9; CRANBERRY EXTRACT; CYANIDIN 3 ARABINOSIDE; CYANIDIN 3 GALACTOSIDE; CYTOCHROME C; FLAVONOID GLYCOSIDE; HYPERIN; MYRICETIN 3 ARABINOSIDE; MYRICETIN 3 GALACTOSIDE; PEONIDIN 3 ARABINOSIDE; PEONIDIN 3 GALACTOSIDE; PROANTHOCYANIDIN; PROTEIN BID; PROTEINASE ACTIVATED RECEPTOR 4; QUERCETIN 3 ARABINOFURANOSIDE; QUERCETIN 3 ARABINOPYRANOSIDE; QUERCETIN 3 XYLOSIDE; QUERCITRIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CRANBERRY; DNA FRAGMENTATION; DRUG CYTOTOXICITY; DRUG ISOLATION; ENZYME ACTIVATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MITOCHONDRION; PROTEIN CLEAVAGE; PROTEIN EXPRESSION;

APOPTOSIS; CASPASE 8; CASPASE 9; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA FRAGMENTATION; FLAVONOIDS; HUMANS; MALE; PLANT EXTRACTS; PROSTATIC NEOPLASMS; VACCINIUM MACROCARPON;

VACCINIUM MACROCARPON;

EID: 78751538283     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581.2010.516876     Document Type: Article

References (32)

1. Canadian Cancer Society/National Cancer Institute of Canada: Canadian Cancer Statistics 2007. Canadian Cancer Society/National Cancer Institute of Canada, Toronto, Canada, 2007.
2. American Cancer Society: Cancer Facts and Figures 2007. American Cancer Society, Atlanta, 2007.
3. Raghavan D, Koczwara B, and Javle M: Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer. Eur J Cancer 33, 566-574, 1997.
4. Navarro D, Luzardo OP, Fernandez L, Chesa N, and Diaz-Chico BN: Transition to androgen-independence in prostate cancer. J Steroid Biochem Mol Biol 81, 191-201, 2002.
5. Lippert MC, McClain R, Boyd JC, and Theodorescu D: Alternative medicine use in patients with localized prostate carcinoma treated with curative intent. Cancer 86, 2642-2648, 1999.
6. Kao GD, and Devine P: Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy. Cancer 88, 615-619, 2000.
7. Bemis DL, Capodice JL, Costello JE, Vorys GC, Katz AE, et al.: The use of herbal and over-the-counter dietary supplements for the prevention of prostate cancer. Curr Urol Rep 7, 166-74, 2006.
8. Mazhar D and Waxman J: Diet and prostate cancer. BJU Int 93, 919-922, 2004.
9. Nguyen JY, Major JM, Knott CJ, Freeman KM,Downs TM, et al.:Adoption of a plant-based diet by patients with recurrent prostate cancer. Integr Cancer Ther 5, 214-223, 2006.
10. Barnes S: Role of phytochemicals in prevention and treatment of prostate cancer. Epidemiol Rev 23, 102-105, 2001.
11. Campbell JK, Canene-Adams K, Lindshield BL, Boileau TW, Clinton SK, et al.: Tomato phytochemicals and prostate risk. J Nutr 134, 3486S-3492S, 2004.
12. Cook LS, Goldoft M, Schwartz SM, Weiss NS: Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J Urol 161, 152-155, 1999.
13. Schulman CC, Ekane S, and Zlotta AR: Nutrition and prostate cancer: evidence or suspicion? Urology 58, 318-334, 2001.
14. Neto CC: Cranberry and its phytochemicals: a review of the in vitro anticancer studies. J Nutr 137, 186S-193S, 2007.
15. Yan X, Murphy BT, Hammond GB, Vinson JA, and Neto CC: Antioxidant activities and antitumor screening of extracts from cranberry fruit (Vaccinium macrocarpon). J Agric Food Chem 50, 5844-584, 2001.
16. Murphy BT, MacKinnon SL, Yan X, Hammond GB, Vaisberg AJ, et al.: Identification of triterpene hydroxycinnamates with in vitro antitumour activity from whole cranberry fruit (Vaccinium macrocarpon). J Agric Food Chem 51, 4541-4545, 2003.
17. Seeram NP, Adams LS, Hardy ML, and Heber D: Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J Agric Food Chem 52, 2512-2517, 2004.
18. Ferguson PJ,Kurowska E, Freeman DJ, Chambers AF, andKoropatnick DJ: Flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. J Nutr 134, 1529-1535, 2004.
19. Boivin D, Blanchette M, Barrette S, Moghrabi A, and Beliveau R: Inhibition of cancer cell proliferation and suppression of TNF-induced activation of NF-ê B by edible berry juice. Anticancer Res 27, 937-948, 2007.
20. Sun J and Liu RH: Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells. Cancer Lett 241, 124-134, 2006.
21. Rimando AM, Wilhelmina K, Magee JB, Dewey J, Ballington JR, et al.: Resveratrol, pterostilbene, and piceatannol in Vaccinium berries. J Agric Food Chem 52, 4713-4719, 2004.
22. Bakhtiarova A., Taslimi P, Elliman SJ, Kosinski PA, Hubbard B, et al.: Resveratrol inhibits firefly luciferase. Biochem Biophys Res Commun 351, 481-484, 2006.
23. Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, et al.: A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome C during apoptosis. Dev Cell 2, 55-67, 2001.
24. Wesselborg S, Engels IH, Rossmann E, Los M, and Schulze-Osthoff K: Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. Blood 93, 3053-3063, 1991.
25. Sells SF, Wood DP, Joshi-Barve SS, Muthukumar S, Jacob RJ, et al.: Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and independent prostate cells. Cell Growth Differ 5, 457-466, 1994.
26. Schmidt BM, Erdman JW, Jr., and Lila MA: Differential effects of blueberry proanthocyanidins on androgen sensitive and insensitive human prostate cancer cell lines. Cancer Lett 231, 240-246, 2006.
27. Qui G, Ahmed M, Sells SF, Mohiiudin M, Weinstein MH, et al.: Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4. Oncogene 18, 623-631, 1999.
28. Neto CC, Krueger CG, Lamoureaux TL, Kondo M, Vaisberg AJ, et al.: MALDI-TOF MS characterization of proanthocyanidins from cranberry fruit (Vaccinium macrocarpon) that inhibit tumor cell growth and matrix metalloproteinase expression in vitro. J Sci Food Agric 86, 18-25, 2006.
29. Vvedenskaya IO, Rosen RT, Guido JE, Russel DJ, Mills KA, et al.: Characterization of flavonols in cranberry (Vaccinium macrocarpon) powder. J Agric Food Chem 52, 188-195, 2004.
30. Neto CC, Sweeney-Nixon MI, Lamoureaux TL, Solomon F, Kondo M, et al.: Cranberry phenolics: effects on oxidative processes, neuron cell death, and tumor cell growth. In: Symposium Series on Phenolics in Foods and Natural Health Products, F Shahidi, C-T Ho (Eds.). ACS Books, Washington, DC, pp. 271-281, 2005.
31. Chakraborty M, Qiu SG, Vasudevan KM, and Rangnekar VM: Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression. Cancer Res 61, 7255-7263, 2001
32. Boehrer S, Chow KU, Beske F, Kukoc-Zivojnov N, Puccetti E, et al.: In lymphatic cells par-4 sensitizes to apoptosis by down-regulating bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation. Cancer Res 62, 1768-1775, 2002.